Drug repurposing is a strategy that aims to develop novel cancer treatments through the
reuse of existing medicines developed in other disease areas. Such a strategy includes the …

Repurposing refers to the therapeutic use of a drug or drug candidate for a disease other
than that for which it was originally intended. Repurposing is attractive as a drug …

Drug repurposing in cancer taps into the capabilities of existing drugs, initially designed for
other ailments, as potential cancer treatments. It offers several advantages over traditional …

Contrary to the definition of a drug, drug repurposing usually involves the redevelopment of
an active pharmaceutical ingredient (API) for a substantially different medical use; only …

The exploration and identification of new anti-cancer therapeutic indications for an approved
drug already in use, or for a drug that was shelved for non-safety reasons in early clinical …

The costs of developing, validating and buying new drugs are dramatically increasing. On
the other hand, sobering economies have difficulties in sustaining their healthcare systems …

Drug discovery process is a costly and time-consuming task. An average of 12–15 years is
required for a drug to be approved [1]. The investment required to get it increases …

Drug repurposing (an approach to drug development that is also known as drug
repositioning, reprofiling, or retasking) has become a matter of intense interest during the …

Gene mutations are strongly associated with tumor progression and are well known in
cancer development. However, recently discovered epigenetic alterations have shown the …

Drug repurposing is a ray of hope for therapy of various diseases including cancer. Since
historical times, drugs like nitrogen mustards, chlorambucil, etc. have been repurposed in …